Q4 2022 Vistin Pharma ASA Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Vistin Pharma Quarterly Report Q4 2022. (Operator Instructions)
I would now like to turn the conference over to CEO, Kjell-Erik Nordby. Please go ahead. Your line is open.
()
Thank you very much, and welcome to the Fourth Quarter presentation in Vistin Pharma. I will go straight to the highlights for the quarter. And since this is the last quarter in 2022, we will also give you a preliminary update on the overall 2022 results.
In the quarter, we achieved NOK 111 million in revenue compared to NOK 78 million in the same quarter last year. That's a 42% increase. This is the first quarter in Vistin's history that we achieved more than NOK 100 million in revenue in 1 quarter. The revenue increase or the revenue and other income was driven by the factors that we had more volumes available for sale in the quarter and we had a higher average sales price.
In addition to that, we received NOK 13
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
